ArticleDermatology and therapy2026
Window of Opportunity and Predictors of Sustained Remission in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A 540-Patient Cohort Study.
Eva Vilarrasa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.